Immune checkpoint inhibition in patients with inactive pre-existing neuromuscular autoimmune diseases
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference34 articles.
1. Estimation of the percentage of US patients with Cancer who are eligible for immune checkpoint inhibitor drugs;Haslam;JAMA Netw. Open,2020
2. Advances in cancer immunotherapy 2019 – latest trends;Kruger;J. Exp. Clin. Cancer Res.,2019
3. A review of cancer immunotherapy toxicity;Kennedy;CA Cancer J. Clin.,2020
4. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: a review;Khan;Semin. Cancer Biol.,2020
5. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease;European Journal of Cancer;2024-08
2. Neurologic outcomes in people with multiple sclerosis treated with immune checkpoint inhibitors for oncologic indications;2024-06-13
3. Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders;Current Neurology and Neuroscience Reports;2023-10-23
4. Current drug treatment of myasthenia gravis;Current Opinion in Neurology;2023-08-30
5. Toxic neuropathies;Current Opinion in Neurology;2023-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3